High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

被引:200
作者
Ko, Kwan Soo
Suh, Ji Yoeun
Kwon, Ki Tae
Jung, Sook-In
Park, Kyong-Hwa
Kang, Cheol In
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
[3] Asian Pacific Res Fdn Infect Dis ARFID, Seoul 135710, South Korea
[4] Daegu Fatima Hosp, Div Infect Dis, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
关键词
rpoB; antimicrobial resistance; subgrouping;
D O I
10.1093/jac/dkm305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 10 条
[1]   Seven novel species of Acinetobacter isolated from activated sludge [J].
Carr, EL ;
Kämpfer, P ;
Patel, BKC ;
Gürtler, V ;
Seviour, RJ .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2003, 53 :953-963
[2]  
*CLIN LAB STAND I, 2006, PERF STAND ANT SUSC
[3]   Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) [J].
Gales, AC ;
Jones, RN ;
Sader, HS .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (04) :315-321
[4]   Multidrug-resistant Acinetobacter infections:: An emerging challenge to clinicians [J].
Jain, R ;
Danziger, LH .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) :1449-1459
[5]   Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002 [J].
Jones M.E. ;
Draghi D.C. ;
Karlowsky J.A. ;
Sahm D.F. ;
Bradley J.S. .
Annals of Clinical Microbiology and Antimicrobials, 3 (1)
[6]   Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species [J].
La Scola, B ;
Gundi, VAKB ;
Khamis, A ;
Raoult, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :827-832
[7]   Treatment of multidrug resistant Acinetobacter [J].
Murray, CK ;
Hospenthal, DR .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) :502-506
[8]   The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species [J].
Paterson, David L. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 :S43-S48
[9]  
Reis AO, 2003, EMERG INFECT DIS, V9, P1025
[10]   Antimicrobial resistance of Acinetobacter spp. in Europe [J].
Van Looveren, M ;
Goossens, H .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (08) :684-704